Operative treatment of intramedullary hematoma associated with congenital deficiency of alpha 2-plasmin inhibitor, A report of three cases.
Miyauchi
Y
Y
Department of Orthopedic Surgery, Nara Medical University, Japan.
Mii
Y
Y
Aoki
M
M
Tamai
S
S
Takahashi
Y
Y
Yoshioka
A
A
D000293:Adolescent; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001855:Bone Marrow Diseases / Q000601:surgery*; D002648:Child; D003475:Curettage; D017886:Durapatite; D005260:Female; D005269:Femur / Q000601:surgery; D015718:Fibrin Tissue Adhesive / Q000627:therapeutic use; D006406:Hematoma / Q000601:surgery*; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D006811:Humerus / Q000601:surgery; D007717:Knee / Q000601:surgery; D019736:Prostheses and Implants; D011884:Radius / Q000601:surgery; D015842:Serine Proteinase Inhibitors / Q000172:deficiency* / Q000235:genetics; D014148:Tranexamic Acid / Q000627:therapeutic use; D000979:alpha-2-Antiplasmin / Q000172:deficiency* / Q000235:genetics
D000933:Antifibrinolytic Agents; D015718:Fibrin Tissue Adhesive; D006490:Hemostatics; D015842:Serine Proteinase Inhibitors; D000979:alpha-2-Antiplasmin; D014148:Tranexamic Acid; D017886:Durapatite